Clinical effect of Recombinant Human Interferon alpha 2b Vaginal Effervescent Capsules combined with Pidotimod in the treatment of cervical human papillomavirus infection
WANG Jing1 FENG Tongfu1 DU Xin1 ZHENG Rong1 YAN Yuan1 WANG Yan1▲
1.Department of Gynecology, Hubei Maternal and Child Health Hospital, Hubei Province, Wuhan 430070, China;
2.Department of Gynecology, Xiaonan District Maternal and Child Health Hospital, Hubei Province, Xiaogan 432100, China
Abstract：Objective To investigate the curative effect of Recombinant Human Interferon alpha 2b Vaginal Effervescent Capsules(Xinfuning) combined with Pidotimod in the treatment of cervical human papilloma virus (HPV) infection. Methods From January 2014 to December 2018, 100 patients with cervical HPV infection who diagnosed and treated in Materna and Child Health Hospital of Hubei Province were selected. According to the principle of random grouping, there were divided into group A and group B, 50 in each group. Group A was treated with Xinfuning alone and group B was treated with Xinfuning combined with Pidotimod. Reexamination after 6 months of treatment, the levels of plasma T lymphocyte subsets (CD3+, CD4+, CD4+/CD8+) were detected. The therapeutic efficacy, recurrence rate and adverse reactions were analyzed. Results The effective rate of group B was higher than that of group A, the difference was statistically significant (P < 0.05). The levels of plasma T lymphocyte subsets (CD3+, CD4+, CD4+/CD8+) of group B were significantly higher than those of group A, the differences were statistically significant (P < 0.05). The recurrence rate of group B was significantly lower than that of group A, the difference was statistically significant (P < 0.05). The incidence of adverse reactions in group A and group B was basically the same, and there were no statistically significant differences (P > 0.05). Conclusion Xinfuning combined with Pidotimod can effectively improve the immune function of patients with HPV infection, the curative effect and safety, which is worthy of further clinical promotion.
王静1 冯同富1 杜欣1 郑嵘1 晏源2 王燕1▲. 重组人干扰素α2b阴道泡腾胶囊联合匹多莫德治疗宫颈人乳头瘤病毒感染的临床效果[J]. 中国医药导报, 2019, 16(29): 92-95.
WANG Jing1 FENG Tongfu1 DU Xin1 ZHENG Rong1 YAN Yuan1 WANG Yan1▲. Clinical effect of Recombinant Human Interferon alpha 2b Vaginal Effervescent Capsules combined with Pidotimod in the treatment of cervical human papillomavirus infection. 中国医药导报, 2019, 16(29): 92-95.
[1] Katki HA，Schiffman M. A novel metric that quantifies risk stratification for evaluating diagnostic tests：The example of evaluating cervical-cancer screening tests across populations [J]. Prev Med，2018，110：100-105.
[2] Zhou HL，Zhang W，Zhang CJ，et al. Prevalence and distribution of human papillomavirus genotypes in Chinese women between 1991 and 2016：A systematic review [J]. J Infect，2018，76（6）：522-552.
[3] Giugliano S，Kriss M，Golden-Mason L，et al. Hepatitis C virus infection induces autocrine interferon signalingby human liver endothelial cells and release of exosomes，which inhibits viral replication [J]. Gastroenterology，2015， 148（2）：392-402.
[4] Qian HZ，Hu Y，Carlucci JG，et al. Human Immunodeficiency Virus Status Differentially Associated With Genital and Anal Human Papillomavirus Infection Among Chinese Men Who Have Sex With Men：A Cross-Sectional Survey [J]. Sex Transm Dis，2017，44（11）：1.
[5] 吴波，段峥嵘，陈莉，等.宫颈上皮内瘤变患者高危型人乳头状瘤病毒感染LEEP术与保妇康栓联合应用的评价[J].中华医院感染学杂志，2015，25（4）：928-930.
[6] Jraholmen MW，Basnet P，Acharya G，et al. PEGylated liposomes for topical vaginal therapy improve delivery of interferon alpha [J]. Eur J Pharm Biopharm，2017，113：132-139.
[7] 张树丹，李琪，李戈.重组人干扰素α2b阴道泡腾胶囊治疗HPV感染的Meta分析[J].中国医药导报，2017，14（31）：111-115.
[8] Hidalgo-Tenorio C，Rivero-Rodriguez M，Gil-Anguita C，et al. Correction: The role of polymerase chain reaction of high-risk human papilloma virus in the screening of high-grade squamous intraepithelial lesions in the anal mucosa of human immunodeficiency virus-positive males having sex with males [J]. PLoS One，2015，10（5）：e0 128 165.
[9] 丁红炜，张莉，孙越英，等.5-氨基酮戊酸-光动力联合匹多莫德治疗尖锐湿疣临床疗效及对细胞免疫功能的影响[J].河北医科大学学报，2014，35（3）：287-290.
[10] Scheuplein VA，Seifried J，Anna H，et al. High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus [J]. J Virol，2015，89（7）：3859-3869.
[11] 雷蕾.匹多莫德联合干扰素治疗对宫颈人乳头瘤病毒感染患者免疫功能和复发的影响[J].中国病毒病杂志，2017，7（4）：303-308.
[12] 吴帆，宋力雯，成佳景.辛复宁对HPV感染相关的宫颈疾病疗效及对免疫的影响[J].中国计划生育学杂志，2019， 27（3）：320-323.
[13] Caglar GS，Garrido N. The implications of male human papilloma virus infection in couples seeking assisted reproduction technologies [J]. J Turk Ger Gynecol Assoc，2018， 19（1）：48-52.
[14] Woodham AW，Yan L，Skeate JG，et al. T cell ignorance is bliss： T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation [J]. Papillomavirus Res，2016，2：21-30.
[15] 王燕，潘一红，张颖，等.重组人干扰素α-2b阴道泡腾胶囊治疗生殖道HR-HPV感染50例临床观察及护理[J].中国现代医生，2019，57（14）：162-165.
[16] Singh M，Thakral D，Rishi N，et al. Functional characterization of CD4 and CD8 T cell responses among human papillomavirus infected patients with ano-genital warts [J]. Virusdisease，2017，28（2）：133-140.
[17] 胡雅玉，胡恩平，任小丽，等.尖锐湿疣感染患者不同病程Ｔ淋巴细胞亚群的表达与人乳头状瘤病毒感染的相关性研究[J].中华医院感染学杂志，2016，26（10）：2227-2228，2241.
[18] 刘凡，丁艳，尹微等.匹多莫德在幼年特发性关节炎患儿感染预防和免疫调节中的作用分析[J].中华医院感染学杂志，2018，28（23）：3651-3655.
[19] 黄杰鸿，曾仁山.匹多莫德联合阿维A胶囊对复发性尖锐湿疣HPV亚型T淋巴细胞亚群的影响[J].临床医学，2016，36（11）：17-19.
[20] 郑旭，姜薇，高建明，等.匹多莫德联合光动力疗法对女性尖锐湿疣患者皮损朗格汉斯细胞的影响[J].临床和实验医学杂志，2018，17（8）：865-868.
[21] 江泽斌.匹多莫德在小儿慢性扁桃体炎中的临床疗效及对血清IL-4和IFN-γ的影响[J].中国医药科学，2017， 7（16）：51-53，86.
[22] Meng Y，Wang Q，Zhang Z，et al. Synergistic effect of methionine encephalin（MENK）combined with pidotimod（PTD）on the maturation of murine dendritic cells （DCs）[J]. Hum Vaccin Immunother，2013，9（4）：773-783.
2019, Vol. 16 
京公网安备 11010502046598号